AU2017904492A0 - Compositions and methods for the delivery of agents that inhibit gene expression - Google Patents

Compositions and methods for the delivery of agents that inhibit gene expression

Info

Publication number
AU2017904492A0
AU2017904492A0 AU2017904492A AU2017904492A AU2017904492A0 AU 2017904492 A0 AU2017904492 A0 AU 2017904492A0 AU 2017904492 A AU2017904492 A AU 2017904492A AU 2017904492 A AU2017904492 A AU 2017904492A AU 2017904492 A0 AU2017904492 A0 AU 2017904492A0
Authority
AU
Australia
Prior art keywords
delivery
agents
compositions
methods
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017904492A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innate Immunotherapeutics Ltd
Original Assignee
Innate Immunotherapeutics Ltd
Filing date
Publication date
Application filed by Innate Immunotherapeutics Ltd filed Critical Innate Immunotherapeutics Ltd
Publication of AU2017904492A0 publication Critical patent/AU2017904492A0/en
Abandoned legal-status Critical Current

Links

AU2017904492A 2017-11-06 Compositions and methods for the delivery of agents that inhibit gene expression Abandoned AU2017904492A0 (en)

Publications (1)

Publication Number Publication Date
AU2017904492A0 true AU2017904492A0 (en) 2017-11-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP3471778A4 (en) Compositions and methods for delivery of biomacromolecule agents
EP3596213A4 (en) Compositions and methods for enhanced gene expression
EP3386484A4 (en) Compositions and methods for delivery of therapeutic agents
EP3273944A4 (en) Compositions and methods for delivery of biomacromolecule agents
EP3630199A4 (en) Oligonucleotide compositions and methods of use thereof
EP3630788A4 (en) Oligonucleotide compositions and methods of use thereof
EP3630789A4 (en) Oligonucleotide compositions and methods of use thereof
EP3694489A4 (en) Methods and compositions for topical delivery
EP3411414A4 (en) Compositions and methods for targeted cytokine delivery
EP3452597A4 (en) Methods and compositions of biologically active agents
EP3374494A4 (en) Crispr compositions and methods of using the same for gene therapy
EP3300507A4 (en) Gene delivery methods and compositions
EP3355954A4 (en) Delivery methods and compositions
EP3585433A4 (en) Therapeutic compositions and related methods for photoimmunotherapy
EP3458074A4 (en) COMPOSITIONS FOR THE DELIVERY OF tRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH
EP3474857A4 (en) Compositions and methods for the delivery of therapeutics
EP3356529A4 (en) Compositions and methods for inhibiting gene expression of lpa
EP3512554A4 (en) Platelet compositions and methods for the delivery of therapeutic agents
EP3148572A4 (en) Compositions and methods of delivery of deubiquitinase inhibitors
EP3310376A4 (en) Modified therapeutic agents and compositions thereof
EP3387119A4 (en) Improved compositions and methods for viral delivery of neoepitopes and uses thereof
EP3302503A4 (en) Compositions and methods for inhibiting gene expression of hif2alpha
EP3110422A4 (en) Compositions and methods for the delivery of therapeutics
EP3723750A4 (en) Drugs and compositions for ocular delivery
EP3523321A4 (en) Compositions and methods for protein expression and delivery